RXi Pharmaceuticals has named Konstantinos Andrikopoulos as vice president, legal counsel, and chief intellectual property officer.
Andrikopoulos was previously senior patent counsel for Shire Human Genetic Therapies. Before his time at Shire, he worked as a technology specialist, patent agent, and patent attorney for Wolf, Greenfield, and Sacks.
He holds a JD from Suffolk University Law School, a PhD in biomedical sciences from the City University of New York, and a BSc in biophysics from the University of East London.
Miragen Therapeutics said last week that its CSO and co-founder, Eric Olson, was awarded the American Heart Association National Research Achievement Award.
Olson is also a professor and chairman of the molecular biology department at the University of Texas Southwestern Medical Center. The award was given to him for his work in identifying molecular mechanisms that control normal and abnormal growth and development of the heart and cardiovascular system, Miragen said.